|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 309/15 | |
| C07D 263/57 | |||
| A61K 31/185 | |||
| A61K 31/423 | |||
| A61P 3/10 |
| (11) | Patento numeris | 3153501 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16198552.8 |
| Europos patento paraiškos padavimo data | 2009-08-13 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-04-12 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-11-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 88697 P | 2008-08-13 | US |
| (72) |
GOMEZ-GALENO, Jorge E., US
HECKER, Scott J., US
DANG, Qun, US
REDDY, Mali Venkat, US
SUN, Zhili, US
GROTE, Matthew P., US
NGUYEN, Thanh Huu, US
LEMUS, Robert Huerta, US
LI, Haiqing, US
|
| (73) |
Metabasis Therapeutics, Inc.,
3911 Sorrento Valley Boulevard, Suite 110, San Diego, CA 92121,
US
|
| (54) | GLUCAGON ANTAGONISTS |
| GLUCAGON ANTAGONISTS |